Source: European Parliament
In April 2017 the Commission stated, in respect of the use of diclofenac for veterinary purposes in the EU, that:
‘Most Member States indicated that they had still not authorised diclofenac. Those that have authorised products indicated that appropriate safety warnings were included in the product literature and that appropriate measures are in place for the safe disposal of fallen stock and the feeding of carrion to birds of prey.
None of the Member States reported deaths of vultures in their territories and no request was made for the initiation of a referral where the withdrawal of the marketing authorisations of products containing diclofenac would be considered.’
Following on from previous questions on this matter (E-001581/2017, E-3922/2015 and E‐9337/2014), could the Commission provide an update on the use of diclofenac and its consequences on populations of vultures and carrion-eating great eagles, including highly endangered species protected under national and EU legislation, as well as their ecosystems?